Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presence of HIV-1 DRMs As a Risk Factor of Failure of Two Drugs Based ART Regimens, Including LAI ART, in Cohorts of Primary and Secondary DRMs.

NCT06661317 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT06661317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06661317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presence of HIV-1 DRMs As a Risk Factor of Failure of Two Drugs Based ART Regimens, Including LAI ART, in Cohorts of Primary and Secondary DRMs.
Lead sponsor
Medical University of Warsaw
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2024
Completion date
December 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

art, drm, drm gene mutation, hiv-1-infection